Cancer Institute– A national cancer institute
designated cancer center

Mark L. Gonzalgo, M.D., Ph.D.

Back to Profile

Publication Details

  • Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.

    Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML. J Urol. 2007; 178 (4 Pt 1): 1277-80; discussion 1280-1

    We investigated biochemical outcomes following radical prostatectomy across subclassifications of clinical stage T1 prostate cancer.

    PubMedID: 17698121

Stanford Medicine Resources:

Footer Links: